{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T01:25:04Z","timestamp":1766625904552,"version":"3.37.3"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100001844","name":"Scleroderma Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100001844","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Parker B. Francis Foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL131907","HL116315","HL109448"],"award-info":[{"award-number":["HL131907","HL116315","HL109448"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s11926-019-0826-9","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T07:05:06Z","timestamp":1556175906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Novel Imaging Approaches in Systemic Sclerosis-Associated Interstitial Lung Disease"],"prefix":"10.1007","volume":"21","author":[{"given":"Sydney B.","family":"Montesi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Caravan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,25]]},"reference":[{"issue":"3","key":"826_CR1","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1148\/radiology.176.3.2389033","volume":"176","author":"H Schurawitzki","year":"1990","unstructured":"Schurawitzki H, Stiglbauer R, Graninger W, Herold C, P\u00f6lzleitner D, Burghuber OC, et al. Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology. 1990;176:755\u20139.","journal-title":"Radiology"},{"issue":"12","key":"826_CR2","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1002\/art.39405","volume":"67","author":"Yossra A. Suliman","year":"2015","unstructured":"Suliman YA, Dobrota R, Huscher D, Nguyen-Kim TDL, Maurer B, Jordan S, et al. Brief report: pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease. Arthritis Rheumatol. 2015;67:3256\u201361.","journal-title":"Arthritis & Rheumatology"},{"key":"826_CR3","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1136\/ard.2006.066068","volume":"66","author":"VD Steen","year":"2007","unstructured":"Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972\u20132002. Ann Rheum Dis. 2007;66:940\u20134.","journal-title":"Ann Rheum Dis"},{"key":"826_CR4","doi-asserted-by":"crossref","unstructured":"Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med. 2006;354:2655\u201366.","DOI":"10.1056\/NEJMoa055120"},{"issue":"9","key":"826_CR5","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","volume":"4","author":"Donald P Tashkin","year":"2016","unstructured":"Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, et al. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016;4:708\u201319.","journal-title":"The Lancet Respiratory Medicine"},{"issue":"1","key":"826_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1164\/rccm.201803-0444PP","volume":"199","author":"Xiaoping Wu","year":"2019","unstructured":"\u2022 Wu X, Kim GH, Salisbury ML, Barber D, Bartholmai BJ, Brown KK, et al. Computed tomographic biomarkers in idiopathic pulmonary fibrosis. The future of quantitative analysis. Am J Respir Crit Care Med. 2019;199:12\u201321. This perspective piece reviews current quantitative CT metrics and their potential role as imaging biomarkers. While the focus of the perspective is on application to idiopathic pulmonary fibrosis, the techniques and concepts also have high applicability to SSc-ILD.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"22","key":"826_CR7","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1001\/archinternmed.2009.427","volume":"169","author":"Rebecca Smith-Bindman","year":"2009","unstructured":"Smith-Bindman R, Lipson J, Marcus R, Kim K-P, Mahesh M, Gould R, et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med. 2009;169:2078\u201386.","journal-title":"Archives of Internal Medicine"},{"key":"826_CR8","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1136\/annrheumdis-2014-206585","volume":"73","author":"E Picano","year":"2014","unstructured":"Picano E, Semelka R, Ravenel J, Matucci-Cerinic M. Rheumatological diseases and cancer: the hidden variable of radiation exposure. Ann Rheum Dis. 2014;73:2065\u20138.","journal-title":"Ann Rheum Dis"},{"key":"826_CR9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1136\/annrheumdis-2011-200564","volume":"71","author":"A Winklehner","year":"2012","unstructured":"Winklehner A, Berger N, Maurer B, Distler O, Alkadhi H, Frauenfelder T. Screening for interstitial lung disease in systemic sclerosis: the diagnostic accuracy of HRCT image series with high increment and reduced number of slices. Ann Rheum Dis. 2012;71:549\u201352.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"826_CR10","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1136\/annrheumdis-2014-205637","volume":"73","author":"Thomas Frauenfelder","year":"2014","unstructured":"Frauenfelder T, Winklehner A, Nguyen TDL, Dobrota R, Baumueller S, Maurer B, et al. Screening for interstitial lung disease in systemic sclerosis: performance of high-resolution CT with limited number of slices: a prospective study. Ann Rheum Dis. 2014;73:2069\u201373.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"826_CR11","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.21037\/jtd.2018.04.39","volume":"10","author":"TDL Nguyen-Kim","year":"2018","unstructured":"Nguyen-Kim TDL, Maurer B, Suliman YA, Morsbach F, Distler O, Frauenfelder T. The impact of slice-reduced computed tomography on histogram-based densitometry assessment of lung fibrosis in patients with systemic sclerosis. J Thorac Dis. 2018;10:2142\u201352.","journal-title":"J Thorac Dis"},{"key":"826_CR12","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/ard.62.8.728","volume":"62","author":"CL Hill","year":"2003","unstructured":"Hill CL, Nguyen A-M, Roder D, Roberts-Thomson P. Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis. 2003;62:728\u201331.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"826_CR13","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1164\/rccm.201607-1385OC","volume":"195","author":"Margaret L. Salisbury","year":"2017","unstructured":"Salisbury ML, Lynch DA, van Beek EJR, Kazerooni EA, Guo J, Xia M, et al. Idiopathic pulmonary fibrosis: the association between the adaptive multiple features method and fibrosis outcomes. Am J Respir Crit Care Med. 2017;195:921\u20139.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"6","key":"826_CR14","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1164\/rccm.201711-2174OC","volume":"198","author":"J Jacob","year":"2018","unstructured":"Jacob J, Bartholmai BJ, Rajagopalan S, van Moorsel CHM, van Es HW, van Beek FT, et al. Predicting outcomes in idiopathic pulmonary fibrosis using automated CT analysis. Am J Respir Crit Care Med. 2018;198(6):767\u201376.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"826_CR15","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1007\/s00330-011-2223-2","volume":"21","author":"Hyun J. Kim","year":"2011","unstructured":"Kim HJ, Brown MS, Elashoff R, Li G, Gjertson DW, Lynch DA, et al. Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide. Eur Radiol. 2011;21:2455\u201365.","journal-title":"European Radiology"},{"key":"826_CR16","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1513\/AnnalsATS.201802-079OC","volume":"15","author":"JG Goldin","year":"2018","unstructured":"\u2022\u2022 Goldin JG, GHJ K, Tseng C-H, Volkmann E, Furst D, Clements P, et al. Longitudinal changes in quantitative interstitial lung disease on computed tomography after immunosuppression in the Scleroderma Lung Study II. Ann Am Thorac Soc. 2018;15:1286\u201395. This study demonstrates that quantitative CT can detect a decrease in ILD with both cyclophosphamide and mycophenolate mofetil and that such changes in quantitative CT measures correlate with prior reported outcome measures including change in forced vital capacity.","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"826_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s13244-012-0176-x","volume":"3","author":"J. M. Wild","year":"2012","unstructured":"Wild JM, Marshall H, Bock M, Schad LR, Jakob PM, Puderbach M, et al. MRI of the lung (1\/3): methods. Insights Imaging. 2012;3:345\u201353.","journal-title":"Insights into Imaging"},{"issue":"11","key":"826_CR18","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1513\/AnnalsATS.201603-203OC","volume":"13","author":"David J. Roach","year":"2016","unstructured":"Roach DJ, Cr\u00e9millieux Y, Fleck RJ, Brody AS, Serai SD, Szczesniak RD, et al. Ultrashort echo-time magnetic resonance imaging is a sensitive method for the evaluation of early cystic fibrosis lung disease. Ann Am Thorac Soc. 2016;13:1923\u201331.","journal-title":"Annals of the American Thoracic Society"},{"issue":"11","key":"826_CR19","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1007\/s00330-016-4218-5","volume":"26","author":"Ga\u00ebl Dournes","year":"2016","unstructured":"Dournes G, Menut F, Macey J, Fayon M, Chateil J-F, Salel M, et al. Lung morphology assessment of cystic fibrosis using MRI with ultra-short echo time at submillimeter spatial resolution. Eur Radiol. 2016;26:3811\u201320.","journal-title":"European Radiology"},{"issue":"2","key":"826_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1148\/radiol.12110990","volume":"263","author":"Smitha Rajaram","year":"2012","unstructured":"Rajaram S, Swift AJ, Capener D, Telfer A, Davies C, Hill C, et al. Lung morphology assessment with balanced steady-state free precession MR imaging compared with CT. Radiology. 2012;263:569\u201377.","journal-title":"Radiology"},{"issue":"8","key":"826_CR21","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.ejrad.2013.02.031","volume":"82","author":"Yoshiharu Ohno","year":"2013","unstructured":"Ohno Y, Nishio M, Koyama H, Takenaka D, Takahashi M, Yoshikawa T, et al. Pulmonary MR imaging with ultra-short TEs: utility for disease severity assessment of connective tissue disease patients. Eur J Radiol. 2013;82:1359\u201365.","journal-title":"European Journal of Radiology"},{"key":"826_CR22","unstructured":"Mirsadraee S, Tse M, Kershaw L, Semple S, Schembri N, Chin C, et al. T1 characteristics of interstitial pulmonary fibrosis on 3T MRI-a predictor of early interstitial change? Quant Imaging Med Surg. 2016;6:42\u20139."},{"issue":"9","key":"826_CR23","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1007\/s10067-016-3267-0","volume":"35","author":"Iago Pinal-Fernandez","year":"2016","unstructured":"Pinal-Fernandez I, Pineda-Sanchez V, Pallisa-Nu\u00f1ez E, Simeon-Aznar CP, Selva-O'Callaghan A, Fonollosa-Pla V, et al. Fast 1.5 T chest MRI for the assessment of interstitial lung disease extent secondary to systemic sclerosis. Clin Rheumatol. 2016;35:2339\u201345.","journal-title":"Clinical Rheumatology"},{"issue":"2","key":"826_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5152\/dir.2016.15331","volume":"23","author":"Lisa P. Lavelle","year":"2017","unstructured":"Lavelle LP, Brady D, McEvoy S, Murphy D, Gibney B, Gallagher A, et al. Pulmonary fibrosis: tissue characterization using late-enhanced MRI compared with unenhanced anatomic high-resolution CT. Diagn Interv Radiol. 2017;23:106\u201311.","journal-title":"Diagnostic and Interventional Radiology"},{"key":"826_CR25","doi-asserted-by":"crossref","unstructured":"Chassagnon G, Martin C, Marini R, Vakalopolou M, R\u00e9gent A, Mouthon L, Paragios N, Revel MP. Use of elastic registration in pulmonary MRI for the assessment of pulmonary fibrosis in patients with systemic sclerosis. Radiology. 2019;182099.","DOI":"10.1148\/radiol.2019182099"},{"key":"826_CR26","doi-asserted-by":"crossref","unstructured":"Stahl M, Wielp\u00fctz MO, Graeber SY, Joachim C, Sommerburg O, Kauczor H-U, et al. Comparison of lung clearance index and magnetic resonance imaging for assessment of lung disease in children with cystic fibrosis. Am J Respir Crit Care Med. 2017;195:349\u201359.","DOI":"10.1164\/rccm.201604-0893OC"},{"key":"826_CR27","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/RTI.0000000000000392","volume":"34","author":"JG Mammarappallil","year":"2019","unstructured":"Mammarappallil JG, Rankine L, Wild JM, Driehuys B. New developments in imaging idiopathic pulmonary fibrosis with hyperpolarized xenon magnetic resonance imaging. J Thorac Imaging. 2019;34:136\u201350.","journal-title":"J Thorac Imaging"},{"issue":"1","key":"826_CR28","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/mrm.25400","volume":"74","author":"Neil J. Stewart","year":"2014","unstructured":"Stewart NJ, Leung G, Norquay G, Marshall H, Parra-Robles J, Murphy PS, et al. Experimental validation of the hyperpolarized 129 Xe chemical shift saturation recovery technique in healthy volunteers and subjects with interstitial lung disease. Magn Reson Med. 2015;74:196\u2013207.","journal-title":"Magnetic Resonance in Medicine"},{"issue":"5","key":"826_CR29","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/thoraxjnl-2018-211851","volume":"74","author":"Nicholas D Weatherley","year":"2018","unstructured":"Weatherley ND, Stewart NJ, Chan H-F, Austin M, Smith LJ, Collier G, et al. Hyperpolarised xenon magnetic resonance spectroscopy for the longitudinal assessment of changes in gas diffusion in IPF. Thorax. 2018. https:\/\/doi.org\/10.1136\/thoraxjnl-2018-211851 .","journal-title":"Thorax"},{"issue":"1","key":"826_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1172\/JCI122132","volume":"129","author":"Sydney B. Montesi","year":"2019","unstructured":"\u2022 Montesi SB, D\u00e9sog\u00e8re P, Fuchs BC, Caravan P. Molecular imaging of fibrosis: recent advances and future directions. J Clin Invest. 2019;129:24\u201333. This review discusses molecular probes for molecular imaging of fibrosis, summarizes evidence supporting their use, and offers insight as to their potential clinical applications.","journal-title":"Journal of Clinical Investigation"},{"key":"826_CR31","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/chem.201801578","volume":"25","author":"P D\u00e9sog\u00e8re","year":"2019","unstructured":"D\u00e9sog\u00e8re P, Montesi SB, Caravan P. Molecular probes for imaging fibrosis and fibrogenesis. Chemistry. 2019;25:1128\u201341.","journal-title":"Chemistry"},{"key":"826_CR32","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1136\/ard.50.Suppl_4.866","volume":"50","author":"JD Pearson","year":"1991","unstructured":"Pearson JD. The endothelium: its role in scleroderma. Ann Rheum Dis. 1991;50 Suppl 4:866\u201371.","journal-title":"Ann Rheum Dis"},{"issue":"26","key":"826_CR33","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","volume":"315","author":"HF Dvorak","year":"1986","unstructured":"Dvorak HF. Tumors: wounds that do not heal: similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315(26):1650\u20139.","journal-title":"N Engl J Med"},{"key":"826_CR34","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1165\/rcmb.2009-0345OC","volume":"43","author":"BS Shea","year":"2010","unstructured":"Shea BS, Brooks SF, Fontaine BA, Chun J, Luster AD, Tager AM. Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury. Am J Respir Cell Mol Biol. 2010;43:662\u201373.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"826_CR35","first-page":"1933","volume":"35","author":"S Fanti","year":"1994","unstructured":"Fanti S, De Fabritiis A, Aloisi D, Dondi M, Marengo M, Compagnone G, et al. Early pulmonary involvement in systemic sclerosis assessed by technetium-99m-DTPA clearance rate. J Nucl Med. 1994;35:1933\u20136.","journal-title":"J Nucl Med"},{"key":"826_CR36","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1183\/09031936.93.06060797","volume":"6","author":"AU Wells","year":"1993","unstructured":"Wells AU, Hansell DM, Harrison NK, Lawrence R, Black CM, Bois d RM. Clearance of inhaled 99mTc-DTPA predicts the clinical course of fibrosing alveolitis. Eur Respir J. 1993;6:797\u2013802.","journal-title":"Eur Respir J"},{"issue":"1","key":"826_CR37","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1183\/09031936.00010910","volume":"38","author":"N. S. L. Goh","year":"2010","unstructured":"Goh NSL, Desai SR, Anagnostopoulos C, Hansell DM, Hoyles RK, Sato H, et al. Increased epithelial permeability in pulmonary fibrosis in relation to disease progression. Eur Respir J. 2011;38:184\u201390.","journal-title":"European Respiratory Journal"},{"issue":"5","key":"826_CR38","doi-asserted-by":"publisher","first-page":"1800171","DOI":"10.1183\/13993003.00171-2018","volume":"51","author":"Sydney B. Montesi","year":"2018","unstructured":"\u2022 Montesi SB, Rao R, Liang LL, Goulart HE, Sharma A, Digumarthy SR, et al. Gadofosveset-enhanced lung MRI to detect ongoing vascular leak in pulmonary fibrosis. Eur Respir J. 2018;51:1800171. This study demonstrates that albumin extravasation, as a surrogate for vascular leak, is increased in pulmonary fibrosis, including SSc-ILD and that molecular imaging can be utilized to provide insight as to underlying biology in ILD.","journal-title":"European Respiratory Journal"},{"key":"826_CR39","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","volume":"6","author":"D Pattanaik","year":"2015","unstructured":"Pattanaik D, Brown M, Postlethwaite BC, Postlethwaite AE. Pathogenesis of systemic sclerosis. Front Immunol. 2015;6:272.","journal-title":"Front Immunol"},{"key":"826_CR40","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/ar4230","volume":"15","author":"AJ Gilbane","year":"2013","unstructured":"Gilbane AJ, Denton CP, Holmes AM. Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells. Arthritis Res Ther. 2013;15:215.","journal-title":"Arthritis Res Ther"},{"issue":"384","key":"826_CR41","doi-asserted-by":"publisher","first-page":"eaaf4696","DOI":"10.1126\/scitranslmed.aaf4696","volume":"9","author":"Pauline D\u00e9sog\u00e8re","year":"2017","unstructured":"D\u00e9sog\u00e8re P, Tapias LF, Hariri LP, Rotile NJ, Rietz TA, Probst CK, et al. Type I collagen-targeted PET probe for pulmonary fibrosis detection and staging in preclinical models. Sci Transl Med. 2017;9:eaaf4696.","journal-title":"Science Translational Medicine"},{"key":"826_CR42","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/art.30159","volume":"63","author":"E Hsu","year":"2011","unstructured":"Hsu E, Shi H, Jordan RM, Lyons-Weiler J, Pilewski JM, Feghali-Bostwick CA. Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension. Arthritis Rheum. 2011;63:783\u201394.","journal-title":"Arthritis Rheum"},{"key":"826_CR43","doi-asserted-by":"crossref","unstructured":"Chen HH, Waghorn PA, Wei L, Tapias LF, Schu Hle DT, Rotile NJ, et al. Molecular imaging of oxidized collagen quantifies pulmonary and hepatic fibrogenesis. JCI Insight. 2017;2.","DOI":"10.1172\/jci.insight.91506"},{"issue":"33","key":"826_CR44","doi-asserted-by":"publisher","first-page":"9825","DOI":"10.1002\/anie.201704773","volume":"56","author":"Philip A. Waghorn","year":"2017","unstructured":"Waghorn PA, Jones CM, Rotile NJ, Koerner SK, Ferreira DS, Chen HH, et al. Molecular magnetic resonance imaging of lung fibrogenesis with an oxyamine-based probe. Angew Chem Int Ed Engl. 2017;56:9825\u20138.","journal-title":"Angewandte Chemie International Edition"},{"issue":"4","key":"826_CR45","doi-asserted-by":"publisher","first-page":"538","DOI":"10.2967\/jnumed.108.057901","volume":"50","author":"A. M. Groves","year":"2009","unstructured":"Groves AM, Win T, Screaton NJ, Berovic M, Endozo R, Booth H, et al. Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET\/CT. J Nucl Med. 2009;50:538\u201345.","journal-title":"Journal of Nuclear Medicine"},{"issue":"5","key":"826_CR46","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s00259-017-3917-8","volume":"45","author":"Thida Win","year":"2018","unstructured":"Win T, Screaton NJ, Porter JC, Ganeshan B, Maher TM, Fraioli F, et al. Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF). Eur. J. Nucl. Med. Mol. Imaging. 2018;45:806\u201315.","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"3","key":"826_CR47","doi-asserted-by":"publisher","first-page":"1801992","DOI":"10.1183\/13993003.01992-2018","volume":"53","author":"Pauline T. Lukey","year":"2019","unstructured":"Lukey PT, Harrison SA, Yang S, Man Y, Holman BF, Rashidnasab A, et al. A randomised, placebo-controlled study of omipalisib (PI3K\/mTOR) in idiopathic pulmonary fibrosis. Eur Respir J. 2019;53:1801992.","journal-title":"European Respiratory Journal"},{"key":"826_CR48","doi-asserted-by":"crossref","unstructured":"Bondue B, Castiaux A, Van Simaeys G, Mathey C, Sherer F, Egrise D, et al. Absence of early metabolic response assessed by 18F-FDG PET\/CT after initiation of antifibrotic drugs in IPF patients. Respir Res. 2019;20:10.","DOI":"10.1186\/s12931-019-0974-5"},{"issue":"25","key":"826_CR49","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa1510093","volume":"374","author":"Peter Johnson","year":"2016","unstructured":"Johnson P, Federico M, Kirkwood A, Foss\u00e5 A, Berkahn L, Carella A, et al. Adapted treatment guided by interim PET-CT scan in advanced Hodgkin\u2019s lymphoma. N Engl J Med. 2016;374:2419\u201329.","journal-title":"New England Journal of Medicine"},{"issue":"431","key":"826_CR50","doi-asserted-by":"publisher","first-page":"eaan8840","DOI":"10.1126\/scitranslmed.aan8840","volume":"10","author":"Xilin Sun","year":"2018","unstructured":"Sun X, Xiao Z, Chen G, Han Z, Liu Y, Zhang C, et al. A PET imaging approach for determining EGFR mutation status for improved lung cancer patient management. Sci Transl Med. 2018;10:eaan8840.","journal-title":"Science Translational Medicine"},{"key":"826_CR51","unstructured":"Song GG, Bae S-C, Lee YH. Diagnostic accuracy of lung ultrasound for interstitial lung disease in patients with connective tissue diseases: a meta-analysis. Clin Exp Rheumatol. 2016;34:11\u20136."},{"key":"826_CR52","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13075-017-1409-7","volume":"19","author":"Y Wang","year":"2017","unstructured":"Wang Y, Gargani L, Barskova T, Furst DE, Cerinic MM. Usefulness of lung ultrasound B-lines in connective tissue disease-associated interstitial lung disease: a literature review. Arthritis Res Ther. 2017;19:206.","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"826_CR53","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1093\/rheumatology\/kep263","volume":"48","author":"L. Gargani","year":"2009","unstructured":"Gargani L, Doveri M, D'Errico L, Frassi F, Bazzichi ML, Delle Sedie A, et al. Ultrasound lung comets in systemic sclerosis: a chest sonography hallmark of pulmonary interstitial fibrosis. Rheumatology (Oxford). 2009;48:1382\u20137.","journal-title":"Rheumatology"},{"issue":"3","key":"826_CR54","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1136\/annrheumdis-2011-201072","volume":"72","author":"Tatiana Barskova","year":"2012","unstructured":"Barskova T, Gargani L, Guiducci S, Randone SB, Bruni C, Carnesecchi G, et al. Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis. Ann Rheum Dis. 2013;72:390\u20135.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"826_CR55","doi-asserted-by":"publisher","first-page":"364","DOI":"10.5606\/ArchRheumatol.2016.5849","volume":"31","author":"E \u00c7akir Edis","year":"2016","unstructured":"\u00c7akir Edis E, Hatipo\u011flu ON, Pamuk \u00d6N, Mutlucan Eraslan R, Akt\u00f6z M, Tuncel SA. Effectiveness of thoracic ultrasonography in the evaluation of the severity of pulmonary involvement in patients with systemic sclerosis. Arch Rheumatol. 2016;31:364\u201370.","journal-title":"Arch Rheumatol"},{"issue":"7","key":"826_CR56","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1164\/rccm.201707-1446LE","volume":"197","author":"Lida P. Hariri","year":"2018","unstructured":"Hariri LP, Adams DC, Wain JC, Lanuti M, Muniappan A, Sharma A, et al. Endobronchial optical coherence tomography for low-risk microscopic assessment and diagnosis of idiopathic pulmonary fibrosis in vivo. Am J Respir Crit Care Med. 2018;197:949\u201352.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"8","key":"826_CR57","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.1039\/C5SC01258A","volume":"6","author":"Tashfeen Aslam","year":"2015","unstructured":"Aslam T, Miele A, Chankeshwara SV, Megia-Fernandez A, Michels C, Akram AR, et al. Optical molecular imaging of lysyl oxidase activity - detection of active fibrogenesis in human lung tissue. Chem Sci. 2015;6:4946\u201353.","journal-title":"Chemical Science"},{"key":"826_CR58","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/LBR.0000000000000126","volume":"22","author":"O Danilevskaya","year":"2015","unstructured":"Danilevskaya O, Averyanov A, Lesnyak V, Chernyaev A, Sorokina A. Confocal laser endomicroscopy for diagnosis and monitoring of pulmonary alveolar proteinosis. J Bronchol Interv Pulmonol. 2015;22:33\u201340.","journal-title":"J Bronchol Interv Pulmonol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-019-0826-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-019-0826-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-019-0826-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T01:18:41Z","timestamp":1694827121000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-019-0826-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,25]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["826"],"URL":"https:\/\/doi.org\/10.1007\/s11926-019-0826-9","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"type":"print","value":"1523-3774"},{"type":"electronic","value":"1534-6307"}],"subject":[],"published":{"date-parts":[[2019,4,25]]},"assertion":[{"value":"25 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Sydney Montesi receives research support paid to her institution from United Therapeutics. She has received funding from Promedior though her institution. Peter Caravan has >\u20095% equity in Collagen Medical, Factor 1A LLC, and Reveal Pharmaceuticals. He receives research support from Pfizer, Pliant Therapeutics, Indalo Therapeutics, and has been a consultant to Collagen Medical. He is a named inventor on issued or pending patents that cover <sup>68<\/sup>Ga-CBP8, Gd-Hyd, and Gd-OA.Dr. Caravan reports grants from National Heart Lung and Blood Institute, during the conduct of the study; personal fees and other from Collagen Medical LLC, other from Reveal Pharmaceuticals, grants from Indalo Therapeutics, grants from Pliant Therapeutics, outside the submitted work; In addition, Dr. Caravan has a patent US2017360967 pending, and a patent WO2015085005 pending.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines). Figurehas not been published previously; however, the results from this image were published as part of Montesi et al. [\u2022] with all appropriate informed consent obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights Statement"}}],"article-number":"25"}}